Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
2.660
+0.030 (1.14%)
At close: May 9, 2025, 4:00 PM
2.660
0.00 (0.00%)
After-hours: May 9, 2025, 4:14 PM EDT

Cardiff Oncology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
1772896663252635
Upgrade
Market Cap Growth
-12.45%336.64%5.71%-75.20%-60.31%6519.33%
Upgrade
Enterprise Value
98233-13-49121600
Upgrade
Last Close Price
2.664.341.481.406.0117.99
Upgrade
PS Ratio
240.68422.72135.50162.04702.511736.31
Upgrade
PB Ratio
2.503.480.950.591.804.96
Upgrade
P/TBV Ratio
2.503.480.950.591.804.96
Upgrade
EV/Sales Ratio
167.68340.75--338.281640.66
Upgrade
Debt / Equity Ratio
0.020.020.030.030.020.01
Upgrade
Asset Turnover
0.010.010.010.000.000.01
Upgrade
Quick Ratio
6.046.927.2513.5821.5521.46
Upgrade
Current Ratio
6.227.087.4214.2522.2821.79
Upgrade
Return on Equity (ROE)
-74.15%-59.51%-47.07%-31.37%-21.07%-28.50%
Upgrade
Return on Assets (ROA)
-41.00%-34.01%-28.69%-18.77%-12.69%-16.14%
Upgrade
Return on Capital (ROIC)
-48.20%-38.89%-31.37%-19.75%-13.23%-17.28%
Upgrade
Earnings Yield
-27.62%-15.74%-62.67%-61.88%-11.22%-3.04%
Upgrade
FCF Yield
-24.16%-13.08%-47.59%-55.68%-9.22%-2.60%
Upgrade
Buyback Yield / Dilution
-18.88%-6.65%-2.47%-11.71%-86.97%-249.44%
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q